Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Coeptis Therapeutics Holdings (COEP) Return on Assets (2021 - 2025)

Historic Return on Assets for Coeptis Therapeutics Holdings (COEP) over the last 5 years, with Q3 2025 value amounting to 1.04%.

  • Coeptis Therapeutics Holdings' Return on Assets changed N/A to 1.04% in Q3 2025 from the same period last year, while for Sep 2025 it was 1.04%, marking a year-over-year change of. This contributed to the annual value of 1.61% for FY2024, which is 17900.0% up from last year.
  • Per Coeptis Therapeutics Holdings' latest filing, its Return on Assets stood at 1.04% for Q3 2025.
  • In the past 5 years, Coeptis Therapeutics Holdings' Return on Assets ranged from a high of 0.0% in Q4 2021 and a low of 3.8% during Q1 2023
  • For the 5-year period, Coeptis Therapeutics Holdings' Return on Assets averaged around 1.7%, with its median value being 1.13% (2022).
  • In the last 5 years, Coeptis Therapeutics Holdings' Return on Assets plummeted by -33400bps in 2023 and then soared by 24000bps in 2024.
  • Coeptis Therapeutics Holdings' Return on Assets (Quarter) stood at 0.0% in 2021, then tumbled by -54166bps to 1.82% in 2022, then crashed by -99bps to 3.62% in 2023, then skyrocketed by 66bps to 1.22% in 2024, then increased by 15bps to 1.04% in 2025.
  • Its Return on Assets stands at 1.04% for Q3 2025, versus 0.98% for Q2 2025 and 1.01% for Q1 2025.